Rvnc alert: monsey firm of wohl & fruchter investigating fairness of the sale of revance therapeutics to crown laboratories

Monsey, n.y., aug. 12, 2024 (globe newswire) -- the law firm of wohl & fruchter llp is investigating the fairness of the proposed sale of revance therapeutics, inc. (nasdaq: rvnc) (“revance”) to crown laboratories, inc. (“crown”) for $6.66 per share in cash in a tender offer.

RVNC Ratings Summary

RVNC Quant Ranking